© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Shining The Light On A Medical Marvel
Posted 18th December 2019

Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Shining The Light On A Medical Marvel
Advanced Oncotherapy

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

In 2019 alone, nearly nine million people will have died of cancer. If left unchecked, that figure could well rise to over thirteen million every year by 2030. That is a staggering 1,500 deaths per hour. With these statistics in mind, breakthrough technologies represent one of the greatest hopes for cancer patients of both the present and future. Innovative CEOs such as Nicolas Serandour are standing steadfast as medical vanguards, relentlessly pursuing start-of-the-art technologies that can be leveraged in the ongoing fight against cancer.

Conventional treatments for cancer patients include radiation therapy, which is used in up to sixty percent of cases. However, it can come with costly side effects for the patients. Healthy tissue can suffer, causing internal damage that is hard to repair. That’s where Advanced Oncotherapy’s ground-breaking solution comes in. Focused on proton therapy, also known as proton beam therapy, Nicolas has spearheaded a venture that he believes will revolutionise the way physicians treat cancer moving forward. What separates proton therapy from traditional radiation therapy is the ability to target cancerous cells in the body without causing significant damage to the surrounding healthy tissue.
Advanced Oncotherapy’s vision for the future is one where a more affordable, proton-based radiotherapy system saves the lives of countless more cancer patients than ever before. With this innovative new technology proving to be both cost-effective and clinically superior to existing systems, Nicolas wants to make this vision a reality. Since being at the firm, Nicolas has overseen the development of its proprietary proton-based technology, LIGHT®.

Developed in collaboration with the world-renowned CERN in Switzerland, LIGHT® represents the next step in proton beam therapy and particle acceleration that will change the way cancer is approached. LIGHT®’s compact design allows the delivery of proton beams onto a tumour with greater precision, even during organ movement. This is due to LIGHT®’s capability to change the dose and energy very quickly, which is important for an entire class of moving tumours (lung, pancreatic, liver).

Nicolas and his team are also capitalising on LIGHT®’s uniquely small beam size to position the device ahead in the race for delivering what is called “FLASH”: a faster, cheaper approach to proton therapy. A research collaboration with the Cleveland Clinic, that will evaluate the target conformity of proton minibeams, is a significant development as it marks a clear endorsement from one of the most prestigious healthcare institutions in the world.

“Advanced Oncotherapy’s vision for the future is to save the lives of countless more cancer patients than ever before.”

The company has many ongoing discussions and exclusivity arrangements across the world, including great interest from China. Rather than simply boast about a new piece of tech, and expect hospitals to buy it, Nicolas has instead focused on building relationships that are clinically beneficial for all involved. By enabling hospitals to be a part of developing this new particle accelerator and investigating its therapeutic uses, Advanced Oncotherapy and LIGHT® have rapidly become compelling partners.

Nicolas’ success as CEO of Advanced Oncotherapy will soon see the first LIGHT® system implemented in Harley Street, London. An iconic medical location, this latest development sees yet another success secured for Nicolas and his team. As a proton beam accelerator that is far more compact that traditional radiology equipment, LIGHT® being implemented in the basement of two terraced houses in London will hopefully prove that it can be implemented almost anywhere.

Of course, the mark of any great CEO is the ability to recognise the incredible work of the team around them. Since the beginning of his tenure with Advanced Oncotherapy, Nicolas has remained indebted to the outstanding work and devotion of his staff in pursuing their one goal together; to save lives. Nicolas instils in his staff the energy and desire to work collectively as a team in meeting technical milestones set almost thirty months ago. Hiring and partnering with high-calibre experts in radiation and proton therapy, the team Nicolas has built is as much a testament to his success as that of LIGHT® itself.

For Nicolas, the next step is getting LIGHT® into hospitals where it can truly change lives for the better. A well-considered implementation plan is already in place to successfully transform Advanced Oncotherapy into the undisputed commercial leader for proton-based therapy. As the next decade beckons, while Nicolas remains one of the most exciting leaders to watch within oncotherapy, it is his firm’s potential to radically advance humanity’s efforts to defeat cancer for good that is the real draw.

Company: Advanced Oncotherapy
Contact: advancedoncotherapy@fticonsulting.com
Website: https://www.avoplc.com/

Categories: Innovation, Leadership, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
IdeaScale Acquires InnovationManagement.se to Enhance Comprehensive Innovation Offering
Innovation
10/02/2016IdeaScale Acquires InnovationManagement.se to Enhance Comprehensive Innovation Offering

IdeaScale, the California-based innovation management solution, today announced its acquisition of InnovationManagement.se (IM), the world's leading platform for cutting-edge innovation management content, best practices and online training programs.

Read Full PostRead - Eye Icon
International Women’s Day: More Women Than Ever Are Thriving in Previously Male Dominated Industries
Innovation
08/03/2021International Women’s Day: More Women Than Ever Are Thriving in Previously Male Dominated Industries

Women now take up 26% of STEM employees, specifically Mathematics and Physical Science Sectors, a remarkable shift that can help inspire women looking at non-traditional career paths. Plus, with women in the UK 38% more likely to go to university than men; fem

Read Full PostRead - Eye Icon
Gloo Networks PLC IPO
Strategy
04/08/2015Gloo Networks PLC IPO

Gloo Networks PLc IPO

Read Full PostRead - Eye Icon
The Best Business Acquisition Strategies to Help You Achieve Success
News
30/09/2022The Best Business Acquisition Strategies to Help You Achieve Success

‍There are a number of different strategies that businesses can use to acquire other businesses. However, the best strategy for a particular business will depend on a number of factors, including the size and financial condition of the target business,

Read Full PostRead - Eye Icon
International Trade, Maximising Thailand’s Potential
Finance
01/12/2015International Trade, Maximising Thailand’s Potential

Rajah & Tann is the largest firm in Singapore but, with 9 offices and over 500 lawyers in South East Asia, making it the largest Asian headquartered firm in South East Asia.

Read Full PostRead - Eye Icon
Arbitration Lawyer Celebrates Success
Legal
20/08/2020Arbitration Lawyer Celebrates Success

Few can make the claim that their work has influence on an international level. Harish Salve is one of these lucky few. With a career spanning borders, representing businesses and individuals at the very highest levels, he is a worthy winner in this year’s G

Read Full PostRead - Eye Icon
Innovative Healthcare Benefits: How Medicare Enhances Employee Recruitment and Retention
News
01/09/2023Innovative Healthcare Benefits: How Medicare Enhances Employee Recruitment and Retention

In today’s rapidly evolving job market, where top-tier talent is in high demand and competition among employers is fierce, crafting a comprehensive employee benefits package has become a critical factor in attracting and retaining skilled professionals. Whil

Read Full PostRead - Eye Icon
How Workflow helps your Organization Connect Tools and Teams to Drive Productivity
News
06/05/2022How Workflow helps your Organization Connect Tools and Teams to Drive Productivity

A competitive workflow contains effective features and work tools that help organizations accomplish their business process. Workflow tools are simple information systems that allow businesses to build and optimize their processes. The tools help users build a

Read Full PostRead - Eye Icon
Ann Taylor and Loft to be Acquired for $2.16bn
Finance
19/05/2015Ann Taylor and Loft to be Acquired for $2.16bn

One of America's largest women’s apparel companies has added two major brands to its line-up.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow